IHI 2024 

• €16 million consortium grant for Accelerate.EU (2024–2029), supporting the development and clinical translation of next-generation radiotheranostics. TetraKit’s DualFAPi is one of three compounds selected for clinical evaluation. Read more here: https://shorturl.at/if80C